A pre-clinical sign of atherosclerisis is hypertrophy of arterial wall. Femoral intima-media thickness is noninvasive marker of arterial wall alteration, which can easily be assessed by high resolusion B mode ultrasound. Aims: To investigate the correlation between femoral intima-media thickness and the severity of coronary artery diseases. Methods: 111 consecutive patients with coronary artery diseases were enrolled. Femoral intima-media thickness was assessed by B mode ultrasound with 7.5 - 10 MHz probe about 10 - 15 mm before bifurcation to profond and superfacial femoral arteries. The femoral intima-media thickness < 1.0 mm is named as “normal”, ≥ 1.0 mm is “thick” and ≥ 1.5 mm is defined as “atherosclerosic femoral plaque”. The severity of coronary artery diseases was calculated by Gensini Score. Results: Mean femoral intima-media thickness was 1.57 ± 1.23 mm, 55% patients with abnormal femoral intima-media thickness (male 57.0% vs female 50.0%), 36.9% of patients with coronary artery diseases had atherosclerosic femoral plaque. There was a good correlation between femoral intima-media thickness and severity of coronary artery diseases by Gensini score and its risk factors (age, plasma glucose, smoking, hypertension…). Conclusion: Patients with coronary artery diseases are likely to have concomittant peripheral artery disease with high frequency of femoral artery wall changes. Femoral intima-media thickness could be a helpful diagnostic marker and therapeutic points.
Key words: atherosclerisis, Femoral intima-media thickness, coronary artery diseases, femoral intimamedia thickness (F.IMT).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.